EYE » Topics » Non-operating expense.

This excerpt taken from the EYE 8-K filed Oct 31, 2008.

Non-Operating Expense

 

   

Declined 37.9% to $15.2 million, reflecting primarily lower interest expense, a $5.8 million unrealized gain on derivative instruments, a $1.1 million gain on an investment, partially offset by an increase in other non-operating expense due to foreign currency exchange losses.

This excerpt taken from the EYE 8-K filed Aug 4, 2008.

Non-operating Expense

 

   

Declined 3.3% to $22.7 million, reflecting lower interest expense, a $2.7 million unrealized gain on derivative instruments, a $3.9 million realized loss on derivative instruments and a $1.3 million loss on an investment.

This excerpt taken from the EYE 8-K filed May 1, 2008.

Non-operating Expense

 

   

Rose 134.3% to $18.2 million.

 

   

Included a $3.3 million gain on the sale of an investment in SIS AG, Surgical Instruments Systems.

 

   

Higher interest expense due primarily to increased debt associated with the IntraLase acquisition.

This excerpt taken from the EYE 10-Q filed Nov 8, 2006.
Non-operating expense. Interest expense was $9.8 million and $22.3 million in the three and nine months ended September 29, 2006, respectively, compared with $8.8 million and $23.6 million in the three and nine months ended September 30, 2005, respectively. Interest expense in the three and nine months ended September 29, 2006 includes a pro-rata write-off of debt issuance costs of $0.9 million and $3.3 million, respectively. Interest expense in the three and nine months ended September 30, 2005 includes a pro-rata write-off of debt issuance costs of $3.8 million and $5.7 million, respectively.  We anticipate interest expense to increase in 2006 relative to 2005 due to the issuance of $500 million of 3.25% convertible senior subordinated notes in June 2006.

During the three and nine months ended September 29, 2006, we recorded charges of $3.0 million and $18.8 million,

26




respectively, associated with the repurchase of $20 million and $148.9 million, respectively, aggregate principal amount of convertible notes.

We recorded an unrealized gain on derivative instruments of $2.3 million in the three months ended September 29, 2006 and an unrealized loss on derivative instruments of $0.7 million in the nine months ended September 29, 2006, compared to an unrealized gain of $0.2 million and $1.2 million in the three and nine months ended September 30, 2005, respectively. We record as “unrealized (gain) loss on derivative instruments” the mark to market adjustments on the outstanding foreign currency options and forward contracts which we enter into as part of our overall risk management strategy to reduce the volatility of expected earnings in currencies other than the U.S. dollar.  The losses in the first nine months of 2006 were largely attributable to euro and Japanese yen instruments.

This excerpt taken from the EYE 10-Q filed Aug 9, 2006.
Non-operating expense. Interest expense was $8.0 million and $12.5 million in the three and six months ended June 30, 2006, respectively, compared with $8.9 million and $14.7 million in the three and six months ended June 24, 2005, respectively. Interest expense in the three and six months ended June 30, 2006 includes a pro-rata write-off of debt issuance costs of $2.4 million.  Interest expense in the three and six months ended June 24, 2005 includes a pro-rata write-off of debt issuance costs of $1.9 million.  We anticipate interest expense to increase in 2006 relative to 2005 due to the issuance of $500 million of 3.25% convertible senior subordinated notes in June 2006.

During the three and six months ended June 30, 2006, we recorded a loss of $15.8 million associated with the repurchase of $128.9 million aggregate principal amount of convertible notes.

We recorded an unrealized loss on derivative instruments of $2.4 million and $2.9 million in the three and six months ended June 30, 2006, respectively, compared to an unrealized gain of $0.5 million and $1.0 million in the three and six months ended June 24, 2005, respectively. We record as “unrealized (gain) loss on derivative instruments” the mark to market adjustments on the outstanding foreign currency options and forward contracts which we enter into as part of our overall risk management strategy to reduce the volatility of expected earnings in currencies other than the U.S. dollar.  The losses in the first six months of 2006 were largely attributable to euro and Japanese yen instruments.

This excerpt taken from the EYE 10-Q filed May 10, 2006.
Non-operating expense. Interest expense was $4.5 million and $5.8 million in the three months ended March 31, 2006 and March 25, 2005, respectively. We anticipate interest expense to decrease in 2006 relative to 2005 due to the anticipated overall reduction in average borrowings outstanding during 2006 as well as the higher percentage of our relatively low fixed rate convertible debt versus our higher variable rate debt. The anticipated increase in interest rates throughout 2006 would slightly offset these benefits.

 

We recorded an unrealized loss on derivative instruments of $0.4 million in the three months ended March 31, 2006 compared to an unrealized gain of $0.5 million in the three months ended March 25, 2005. We record as “unrealized (gain) loss on derivative instruments” the mark to market adjustments on the outstanding foreign currency options and forward contracts which we enter into as part of our overall risk management strategy to reduce the volatility of expected earnings in currencies other than the U.S. dollar.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki